Foscarnet: Difference between revisions
From IDWiki
(Created page with "* Inhibits DNA polymerase in human herpesviruses * Indications: {{#ask: Is treated by::foscarnet | default=none}} Category:Antivirals") |
No edit summary |
||
| Line 1: | Line 1: | ||
| + | == Background == |
||
| ⚫ | |||
| + | |||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
| + | |||
| + | === Spectrum of Activity === |
||
| + | |||
| + | * Active against all [[human herpesviruses]] |
||
[[Category:Antivirals]] |
[[Category:Antivirals]] |
||
Revision as of 21:14, 11 September 2020
Background
- Inhibits DNA polymerase in human herpesviruses
- Indications: CMV after hematopoietic stem cell transplantation, CMV after solid organ transplantation, Cytomegalovirus, Herpes simplex virus, Herpesviridae, Post-transplant acute limbic encephalitis
Spectrum of Activity
- Active against all human herpesviruses
References
- ^ Dushyantha T. Jayaweera. Minimising the Dosage-Limiting Toxicities of Foscarnet Induction Therapy. Drug Safety. 1997;16(4):258-266. doi:10.2165/00002018-199716040-00003.
